Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561364 · ClinicalTrials.gov registry record
Biophysical Profile in Preterm Pregnancies
A clinical trial, sponsored by University of Tennessee.
- Completed
- Registry status
- 100
- Enrollment target
NCT02561364: Completed study, sponsored by University of Tennessee.
NCT02561364 is a clinical trial that has completed, run by University of Tennessee. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02561364 has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the fetal biophysical profile (BPP) scoring in pregnant women from 20 weeks-0 days' to 36 weeks-6 days' gestation. A biophysical profile (BPP) is a score that is intended to assess fetal well-being. This test will be performed within the expected time of the routine ultrasound exam.
Primary Outcome
will be monitored and recorded on all participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-03 |
What the finished NCT02561364 record still lists
NCT02561364 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02561364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02561364 about?
NCT02561364 is a clinical study titled "Biophysical Profile in Preterm Pregnancies". The purpose of this study is to evaluate the fetal biophysical profile (BPP) scoring in pregnant women from 20 weeks-0 days' to 36 weeks-6 days' gestation. A biophysical profile (BPP) is a score that is intended to assess fetal well-being. This test will be performed within the expected time of the ...
What is the current status of trial NCT02561364?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-10. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT02561364?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia